- Pharma giant Regeneron to buy 23andMe and its customers’ data for $256M TechCrunch
- Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million CNN
- Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million WSJ
- Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale GlobeNewswire
- 23andMe Sells Gene-Testing Business to DNA Drug Maker Regeneron Bloomberg.com